Skip Navigation

U S Department of Health and Human Services www.hhs.govOffice of Public Health and Science
WomensHealth.gov - The Federal Source for Women's Health Information Sponsored by the H H S Office on Women's Health
1-800-994-9662. TDD: 1-888-220-5446

April 09, 2008

Caffeine May Block High Cholesterol Linked to Alzheimer's

WEDNESDAY, April 9 (HealthDay News) -- A little caffeine every day could offer some protection from Alzheimer's disease for people with high cholesterol.

Rabbits given the daily caffeine equivalent of one cup of coffee and fed a cholesterol-rich diet for 12 weeks suffered relatively little damage in their blood-brain barrier (BBB), which protects the central nervous system from the rest of the body's circulation, new research found.

The findings were published in the open-access publication Journal of Neuroinflammation.

Previous studies have shown that high levels of cholesterol break down the BBB, exposing the central nervous system to damage from blood-borne contamination. BBB leakage occurs in a variety of neurological disorders such as Alzheimer's disease.

"High levels of cholesterol are a risk factor for Alzheimer's disease, perhaps by compromising the protective nature of the blood-brain barrier. For the first time, we have shown that chronic ingestion of caffeine protects the BBB from cholesterol-induced leakage," Jonathan Geiger, of the University of North Dakota School of Medicine and Health Sciences, said in a prepared statement.

Caffeine appears to offer protection by helping proteins maintain the tight binding of the cells in the BBB, so they stop unwanted molecules from entering the central nervous system.

The findings also confirm previous studies showing that caffeine protects against memory loss in aging and in Alzheimer's disease.

"Caffeine is a safe and readily available drug, and its ability to stabilize the blood-brain barrier means it could have an important part to play in therapies against neurological disorders," Geiger said.

More information

The U.S. National Institute on Aging has more about Alzheimer's medications.

-- Kevin McKeever
SOURCE: BioMed Central, news release, April 2, 2008
id=614253

Skip navigation

This site is owned and maintained by the Office on Women's Health
in the U.S. Department of Health and Human Services.

Icon for portable document format (Acrobat) files You may need to download a free PDF reader to view files marked with this icon.


Home | Site index | Contact us

Health Topics | Tools | Organizations | Publications | Statistics | News | Calendar | Campaigns | Funding Opportunities
For the Media | For Health Professionals | For Spanish Speakers (Recursos en Español)

About Us | Disclaimer | Freedom of Information Act Requests | Accessibility | Privacy

U S A dot Gov: The U.S. Government's Official Web Portal